CANNASIGNALโ„ข
LIVE DATA
๐Ÿ”
SIGNAL
HEMP BAN: Federal intoxicating-hemp ban takes effect Nov 12-13, 2026 โ€” consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress โ€” 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) โ€” rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 โ€” license applications open Feb 1, 2027IL: SB 3222 omnibus signed โ€” possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court โ€” repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed โ€” hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program โ€” bipartisan opposition buildingHEMP BAN: Federal intoxicating-hemp ban takes effect Nov 12-13, 2026 โ€” consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress โ€” 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) โ€” rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 โ€” license applications open Feb 1, 2027IL: SB 3222 omnibus signed โ€” possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court โ€” repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed โ€” hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program โ€” bipartisan opposition building

FEDERAL TRACKER

FEDERAL CANNABIS BILLS ยท RESCHEDULING ยท HEMP POLICY

FEDERAL CANNABIS BILLS
FEDERAL BILL LIST CURATED FROM CONGRESS.GOV ยท REVIEWED PERIODICALLY
FEDERAL RESCHEDULING
MEDICAL CANNABIS โ†’ SCHEDULE III
Effective Apr 28, 2026 ยท First federal rescheduling in 55 years
BIFURCATED
DOJ Final Order (Apr 23) moves state-licensed medical cannabis and FDA-approved marijuana drugs from Schedule I to Schedule III. Recreational/adult-use cannabis remains Schedule I. Synthetic THC and hemp-derived products are unaffected. The order is described by working cannabis attorneys as underdrafted, creating bifurcated outcomes โ€” meaningful relief for a narrow cohort of operators, continued uncertainty for the majority.
WHAT CHANGED
  • Section 280E lifted for DEA-registered medical operators
  • Expedited DEA registration pathway opens (60-day window)
  • Federal acknowledgement of cannabis medical value
  • Foundation laid for further rescheduling action
  • Path to bankruptcy access opens for compliant operators
STILL PENDING
  • 280E status for state-licensed medical operators NOT yet DEA-registered: ambiguous
  • Adult-use markets (the majority of revenue) entirely unaffected
  • Recreational cannabis remains Schedule I
  • Broader adult-use rescheduling still unresolved after the Jul 2026 DEA hearing
  • Banking access still constrained (SAFER pending)
  • Interstate commerce still prohibited; dormant commerce clause challenges incoming
  • DEA cost-plus servicing model details still being defined
  • Treasury/IRS guidance on retrospective 280E relief pending
HEMP INDUSTRY ALERT
Federal Hemp Ban Countdown
H.R. 5371 redefines hemp โ€” most intoxicating hemp products banned Nov 12, 2026. Intervention risk: the White House asked Congress on Jun 24 to delay or replace the ban; delay bills pending in both chambers
CRITICAL
99DAYS UNTIL ENFORCEMENT
WHAT CHANGES
Hemp redefined to include total THC (not just delta-9). Delta-8, THCA, THC beverages, and most edibles effectively banned. Max 0.4mg THC per container.
INDUSTRY IMPACT
$28B+ hemp market at risk. 300,000+ jobs affected. Industry pushing for legislative fix in 2026. States with legal hemp-THC markets face preemption.
FEDERAL POLICY TIMELINE
Key Federal Developments
Major policy events affecting the cannabis industry
POSITIVE NEGATIVE NEUTRAL
Jun 29, 2026
DEA administrative hearing on broader rescheduling โ€” whether all cannabis moves to Schedule III โ€” concluded Jul 16, 2026. HHS and the DOJ argued in favor; Indiana, Idaho, and Nebraska opposed. A non-binding ruling from the chief administrative law judge is pending; observers expect rescheduling to proceed. Parallel challenges to the April order remain pending in the D.C. Circuit.
Jun 24, 2026
SAFER Banking Act refiled in both chambers (Merkley/Joyce) โ€” eighth attempt since 2013; 2026 version extends protections to landlords, accountants, and security providers
Jun 24, 2026
White House asks Congress to delay or replace the Nov 2026 hemp ban โ€” OMB letter to Speaker Johnson requests a regulatory package for intoxicating hemp products or a delay of implementation
Apr 28, 2026
Schedule III rescheduling takes effect upon Federal Register publication. New DEA registration pathway opens for state medical licensees (60-day window). Implementation creates bifurcated outcomes; cannabis bar describes order as underdrafted.
Apr 23, 2026
DOJ Final Order: state-licensed medical cannabis rescheduled from Schedule I to Schedule III. Recreational marijuana remains Schedule I. Section 280E lifted for medical operators.
Apr 2026
Hemp industry pushes legislative fix before Nov 2026 ban takes effect